- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Repurposing the yellow fever vaccine for intratumoral immunotherapy ; volume:12 ; number:1 ; year:2020 ; extent:17
EMBO molecular medicine / European Molecular Biology Organization ; 12, Heft 1 (2020) (gesamt 17)
- Urheber
-
Aznar, Maria Angela
Molina, Carmen
Teijeira, Alvaro
Rodriguez, Inmaculada
Azpilikueta, Arantza
Garasa, Saray
Sanchez‐Paulete, Alfonso R.
Cordeiro, Luna
Etxeberria, Iñaki
Alvarez, Maite
Rius‐Rocabert, Sergio
Nistal‐Villan, Estanislao
Berraondo, Pedro
Melero, Ignacio
- DOI
-
10.15252/emmm.201910375
- URN
-
urn:nbn:de:101:1-2022062807250618625166
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Aznar, Maria Angela
- Molina, Carmen
- Teijeira, Alvaro
- Rodriguez, Inmaculada
- Azpilikueta, Arantza
- Garasa, Saray
- Sanchez‐Paulete, Alfonso R.
- Cordeiro, Luna
- Etxeberria, Iñaki
- Alvarez, Maite
- Rius‐Rocabert, Sergio
- Nistal‐Villan, Estanislao
- Berraondo, Pedro
- Melero, Ignacio
Ähnliche Objekte (12)
Intratumoral immunotherapy with the TLR7/8 agonist 3M-052
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
Facile repurposing of peptide–MHC-restricted antibodies for cancer immunotherapy
mRNA vaccine for cancer immunotherapy
Neoantigen vaccine: an emerging tumor immunotherapy
Diphtheria Toxoid Particles as Q Fever Vaccine
Cytoreduction surgery reduces systemic myeloid suppressor cell populations and restores intratumoral immunotherapy effectiveness
Drug repurposing
Synergistic combination therapy using cowpea mosaic virus intratumoral immunotherapy and Lag-3 checkpoint blockade
Intratumoral pro-oxidants promote cancer immunotherapy by recruiting and reprogramming neutrophils to eliminate tumors
Genetic sequencing of a 1944 Rocky Mountain spotted fever vaccine
Dexosomes as a cell-free vaccine for cancer immunotherapy
Intratumoral immunotherapy with the TLR7/8 agonist 3M-052
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
Facile repurposing of peptide–MHC-restricted antibodies for cancer immunotherapy
mRNA vaccine for cancer immunotherapy
Neoantigen vaccine: an emerging tumor immunotherapy
Diphtheria Toxoid Particles as Q Fever Vaccine
Cytoreduction surgery reduces systemic myeloid suppressor cell populations and restores intratumoral immunotherapy effectiveness
Drug repurposing
Synergistic combination therapy using cowpea mosaic virus intratumoral immunotherapy and Lag-3 checkpoint blockade
Intratumoral pro-oxidants promote cancer immunotherapy by recruiting and reprogramming neutrophils to eliminate tumors
Genetic sequencing of a 1944 Rocky Mountain spotted fever vaccine
Dexosomes as a cell-free vaccine for cancer immunotherapy
Intratumoral immunotherapy with the TLR7/8 agonist 3M-052
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
Facile repurposing of peptide–MHC-restricted antibodies for cancer immunotherapy
mRNA vaccine for cancer immunotherapy
Neoantigen vaccine: an emerging tumor immunotherapy
Diphtheria Toxoid Particles as Q Fever Vaccine
Cytoreduction surgery reduces systemic myeloid suppressor cell populations and restores intratumoral immunotherapy effectiveness
Drug repurposing
Synergistic combination therapy using cowpea mosaic virus intratumoral immunotherapy and Lag-3 checkpoint blockade
Intratumoral pro-oxidants promote cancer immunotherapy by recruiting and reprogramming neutrophils to eliminate tumors
Genetic sequencing of a 1944 Rocky Mountain spotted fever vaccine